drugset
Drugs / Ringer acetate based Del Nido cardioplegia
last change Dec 2025 re-read 3 minutes ago

Ringer acetate based Del Nido cardioplegia

also known as Del Nido
Developed for
myocardial ischemia
Investigated by
Ahmed Ismail Abdelsabour · Amr Ibrahim Abdelaal · Assiut University · Ibrahim Mohamed Imbaby · Mahmoud Mohamed Atef Sallam · Mohamed, Ahmed Abdelhay Mohamed
+1 more · Ramy Mustafa Abdelgawad Mohamed

Trials 1

today NCT06414330 · Ph 3
20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT06414330 Jun 2024 → Nov 2025 myocardial ischemia Assiut University Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ringer acetate based Del Nido cardioplegia ClinicalTrials.gov intervention name — accepted as the source's own label NCT06414330 ↗
Known as Del Nido “Group (D) will receive modified Del Nido cardioplegia (Ringer acetate 1000ml, mannitol 20% 17 ml, magnesium sulphate 10% 20ml, sodium bicarbonate 8.4% 16ml, potassium chloride...” NCT06414330 ↗
Route Other “cardioplegia will be injected between the aortic valve and aortic cross clamp” NCT06414330 ↗